Tune in to hear our brilliant panel sharing expert insights and guidance including:
Exploring R&D challenges at big pharma vs. startups The benefits of capability driven M&A and strategic partnerships The future of High-growth therapies and healthcare innovation
Anne Dhulesia, Partner, Life Sciences - LEK Life Science Asif Jan, Group Director, Personalised Healthcare Data Science, Neuroscience Analytics - Roche Alexander Nuyken, Partner, Head of Life Science Strategy and Transactions Advisory, EMEIA - EY